Tumorigenesis and the angiogenic switch

Cited by (1,009)

Items 101–200 of 1,009

1. Mesenchymal stem/stromal cells as a pharmacological and therapeutic approach to accelerate angiogenesis
   Annelies Bronckaers, Petra Hilkens, Wendy Martens, Pascal Gervois, Jessica Ratajczak, Tom Struys, Ivo Lambrichts · 2014 · Pharmacology & Therapeutics
2. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways
   Tingfang Yi, Sung‐Gook Cho, Zhengfang Yi, Xiufeng Pang, Melissa Rodríguez, Ying Wang, Gautam Sethi, Bharat Bhushan Aggarwal, Mingyao Liu · 2008 · Molecular Cancer Therapeutics
3. Adipocyte-derived endotrophin promotes malignant tumor progression
   Park, Jiyoung, Scherer, Philipp E. · 2012 · Journal of Clinical Investigation
4. In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles
   Feng Chen, Hao Hong, Yin Zhang, Hector F. Valdovinos, Sixiang Shi, Glen S. Kwon, Charles P. Theuer, Todd E. Barnhart, Weibo Cai · 2013 · ACS Nano
5. Stress and cancer: mechanisms, significance and future directions
   Eckerling, Anabel, Ricon-Becker, Itay, Sorski, Liat, Sandbank, Elad, Ben-Eliyahu, Shamgar · 2021 · Nature Reviews Cancer
6. The pathophysiologic role of VEGF in hematologic malignancies: therapeutic implications
   Klaus Podar, Kenneth Carl Anderson · 2004 · Blood
7. Emerging roles of ECM remodeling processes in cancer
   Vishnu Mohan, Alakesh Das, Irit Sagi · 2019 · Seminars in Cancer Biology
8. Targeting the tumor vasculature to enhance T cell activity
   Evripidis Lanitis, Melita B. Irving, George Coukos · 2015 · Current Opinion in Immunology
9. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
   Zhongxing Liang, Joann Brooks, Margaret T. Willard, Ke Liang, Younghyoun Yoon, Seunghee Kang, Hyunsuk Shim · 2007 · Biochemical and Biophysical Research Communications
10. Stimuli‐responsive nanotherapeutics for precision drug delivery and cancer therapy
    Qiao, Yiting, Wan, Jianqin, Zhou, Liqian, Ma, Wen, Yang, Yuanyuan, Luo, Weixuan, Yu, Zhiqiang, Wang, Hangxiang · 2019 · WIREs Nanomedicine and Nanobiotechnology
11. Vascular remodeling by intussusceptive angiogenesis
    Valentin Djonov, Oliver Baum, Peter H. Burri · 2003 · Cell and Tissue Research
12. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma
    Arne Östman · 2004 · Cytokine & Growth Factor Reviews
13. Imaging Angiogenesis: Applications and Potential for Drug Development
    Janet C. Miller, Homer H. Pien, Dushyant Vasudeo Sahani, Alma Gregory Sorensen, James H. Thrall · 2005 · JNCI Journal of the National Cancer Institute
14. Role of the tumor microenvironment in tumor progression and the clinical applications (Review)
    YUAN, YAO, JIANG, YU-CHEN, SUN, CHONG-KUI, CHEN, QIAN-MING · 2016 · Oncology Reports
15. Neutrophils: key mediators of tumour angiogenesis
    Simon J. Tazzyman, Claire E. Lewis, Craig Murdoch · 2009 · International Journal of Experimental Pathology
16. <scp>pH</scp> ‐Sensitive stimulus‐responsive nanocarriers for targeted delivery of therapeutic agents
    Karimi, Mahdi, Eslami, Masoud, Sahandi‐Zangabad, Parham, Mirab, Fereshteh, Farajisafiloo, Negar, Shafaei, Zahra, Ghosh, Deepanjan, Bozorgomid, Mahnaz, Dashkhaneh, Fariba, Hamblin, Michael R. · 2016 · WIREs Nanomedicine and Nanobiotechnology
17. Lymphoma-Specific Genetic Aberrations in Microvascular Endothelial Cells in B-Cell Lymphomas
    Berthold Streubel, Andreas Chott, Daniela Huber, Markus Exner, Ulrich Jaeger, Oswald F Wagner, Ilse Schwarzinger · 2004 · New England Journal of Medicine
18. Nanoparticles' interactions with vasculature in diseases
    Jie Kai Tee, Li Xian Yip, Eveline Sheau Tan, Supawan Santitewagun, Arun Prasath, Pu Chun Ke, Han Kiat Ho, David Tai Leong · 2019 · Chemical Society Reviews
19. Nanomaterials for Cancer Therapy and Imaging
    Ki Hyun Bae, Hyun Jung Chung, Tae Gwan Park · 2011 · Molecules and Cells
20. CXCR3 ligands in disease and therapy
    Katrien Van Raemdonck, Philippe E. Van den Steen, Sandra Liekens, Jo Van Damme, Sofie Struyf · 2014 · Cytokine & Growth Factor Reviews
21. Molecular interactions in cancer cell metastasis
    Susan Ann Brooks, Hannah J. Lomax-Browne, Tracey M. Carter, C. Kinch, Debbie Hall · 2009 · Acta Histochemica
22. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer.
    S. Braunstein, Ksenia Karpisheva, C. Pola, J. Goldberg, T. Hochman, H. Yee, J. Cangiarella, Rezina Arju, S. Formenti, R. Schneider · 2007 · Molecules and Cells
23. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis
    K. Kishimoto, Shu-Mei Liu, T. Tsuji, K. Olson, G. Hu · 2005 · Oncogene
24. Coordination of Intratumoral Immune Reaction and Human Colorectal Cancer Recurrence
    Matthieu Camus, Marie Tosolini, Bernhard Mlecnik, Franck Pagès, Amos Kirilovsky, Anne Berger, Anne Costes, Gabriela Bindea, Pornpimol Charoentong, Patrick Bruneval et al. · 2009 · Cancer Research
25. Tissue-Infiltrating Neutrophils Constitute the Major In Vivo Source of Angiogenesis-Inducing MMP-9 in the Tumor Microenvironment
    Elena I. Deryugina, Ewa Zając, Anna Juncker‐Jensen, Tatyana A. Kupriyanova, Lisa M. Welter, James P. Quigley · 2014 · Neoplasia
26. Gliomas and the vascular fragility of the blood brain barrier
    Luiz Gustavo Dubois, Loraine Campanati, Cássia Righy, Isabella D’Andrea Meira, Tânia Cristina Leite de Sampaio e Spohr, Isabel Porto-Carreiro, Cláudia Maria Pereira, Joana Balça-Silva, Suzana Assad Kahn, Marcos Fabio Henriques DosSantos et al. · 2014 · Frontiers in Cellular Neuroscience
27. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer
    Daniela Unterleuthner, Patrick Neuhold, Katharina Schwarz, Lukas Janker, Benjamin Neuditschko, Harini Nivarthi, Ilija Crnčec, Nina Kramer, Christine Unger, Markus Hengstschläger et al. · 2019 · Angiogenesis
28. ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
    Qi Zhang, Si-Hong Lu, Tianfu Li, Liang Yu, Yunjian Zhang, Huijuan Zeng, Xueke Qian, Jiong Bi, Ying Lin · 2019 · Journal of Experimental & Clinical Cancer Research
29. Lipoxygenase metabolism: roles in tumor progression and survival
    Graham P. Pidgeon, Joanne Lysaght, Sriram Krishnamoorthy, John Vincent Reynolds, Kenneth John O'Byrne, Daotai Nie, Kenneth V. Honn · 2007 · Cancer and Metastasis Reviews
30. Atu027, a Liposomal Small Interfering RNA Formulation Targeting Protein Kinase N3, Inhibits Cancer Progression
    Manuela Aleku, Petra M. Schulz, Oliver Keil, Ansgar Santel, Ute Schaeper, Britta Dieckhoff, Oliver Janke, Jens Endruschat, Birgit Durieux, Nadine Röder et al. · 2008 · Cancer Research
31. Breast cancer metastasis
    Olivia Jane Scully, Boon‐Huat Bay, George Yip, Yingnan Yu · 1926 · The American Journal of Surgery
32. Metastatic Cancer Cell
    Marina Bacac, Ivan Stamenkovic · 2008 · Annual Review of Pathology Mechanisms of Disease
33. Redox signaling and cancer: The role of “labile” iron
    Galaris, Dimitrios, Skiada, Vasiliki, Barbouti, Alexandra · 2008 · Cancer Letters
34. Targeting the Tumor Microenvironment: From Understanding Pathways to Effective Clinical Trials
    Fang Hua, Yves Albert DeClerck · 2013 · Cancer Research
35. Soy isoflavones and prostate cancer: A review of molecular mechanisms
    Abeer Mostafa Mahmoud, Wancai Yang, Maarten C. Bosland · 2013 · The Journal of Steroid Biochemistry and Molecular Biology
36. Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention
    Ailian Xiong, Zhengduo Yang, Yi‐Cheng Shen, Jia Zhou, Qiang Shen · 2014 · Cancers
37. Managing Patients Treated with Bevacizumab Combination Therapy
    Michael S. Gordon, David Cunningham · 2005 · Oncology
38. Repurposing Drugs in Oncology (ReDO)—chloroquine and hydroxychloroquine as anti-cancer agents
    Ciska Verbaanderd, Hannelore Maes, Marco B.E. Schaaf, Vikas P. Sukhatme, Pan Pantziarka, Vidula V. Sukhatme, Patrizia Agostinis, Gauthier Bouche · 2017 · ecancermedicalscience
39. Multicellular spheroid based on a triple co-culture: A novel 3D model to mimic pancreatic tumor complexity
    Lazzari, Gianpiero, Nicolas, Valérie, Matsusaki, Michiya, Akashi, Mitsuru, Couvreur, Patrick, Mura, Simona · 2018 · Acta Biomaterialia
40. Glioblastoma, a Brief Review of History, Molecular Genetics, Animal Models and Novel Therapeutic Strategies
    Sameer Agnihotri, Kelly E. Burrell, Amparo Wolf, Sharzhad Jalali, Cynthia E Hawkins, James T. Rutka, Gelareh Mohammed Zadeh · 2012 · Archivum Immunologiae et Therapiae Experimentalis
41. Loss of p53 in enterocytes generates an inflammatory microenvironment enabling invasion and lymph node metastasis of carcinogen-induced colorectal tumors
    Schwitalla, Sarah, Ziegler, Paul K., Horst, David, Becker, Valentin, Kerle, Irina, Begus-Nahrmann, Yvonne, Lechel, André, Rudolph, K. Lenhard, Langer, Rupert, Slotta-Huspenina, Julia et al. · 2013 · Cancer Cell
42. Early Contribution of Pericytes to Angiogenic Sprouting and Tube Formation
    Uğur Özerdem, William B. Stallcup · 2003 · Angiogenesis
43. RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
    Hemant Kumar Bid, Ryan David Roberts, Parmeet Kaur Manchanda, Peter J. Houghton · 2013 · Molecular Cancer Therapeutics
44. Engineered Nanomaterials for Infection Control and Healing Acute and Chronic Wounds
    Madasamy Parani, Giriraj K. Lokhande, Ankur K. Singh, Akhilesh K. Gaharwar · 2016 · ACS Applied Materials & Interfaces
45. PDGF and Vessel Maturation
    Carina B. Hellberg, Arne Östman, Carl‐Henrik Heldin · 2009 · Recent results in cancer research/Recent Results in Cancer Research
46. Quercetin-nanostructured lipid carriers: Characteristics and anti-breast cancer activities in vitro
    Ming Sun, Shufang Nie, Xuan Pan, Ruiwen Zhang, Zhaoyang Fan, Shu Fen Wang · 2013 · Colloids and Surfaces B Biointerfaces
47. Angiogenic capacity of M1- and M2-polarized macrophages is determined by the levels of TIMP-1 complexed with their secreted proMMP-9
    Ewa Zając, Bernhard Schweighofer, Tatyana A. Kupriyanova, Anna Juncker‐Jensen, Petra Minder, James P. Quigley, Elena I. Deryugina · 2013 · Blood
48. Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome
    Jose G. Teodoro, Sara K. Evans, Michael R. Green · 2007 · Journal of Molecular Medicine
49. Microvascular density and hypoxia-inducible factor pathway in pancreatic endocrine tumours: negative correlation of microvascular density and VEGF expression with tumour progression
    Anne Couvelard, Dermot O’Toole, Helen Turley, Russell Leek, Alain Sauvanet, Claude Degott, Philippe B Ruszniewski, Jacques Belghiti, Adrian Llewellyn Harris, Kevin C. Gatter et al. · 2004 · British Journal of Cancer
50. Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
    Cristina Blázquez, Luis González‐Feria, Luis Álvarez, Amador Haro, M. Casanova, Manuel Guzmán · 2004 · Cancer Research
51. The chemokine system – a major regulator of angiogenesis in health and disease
    METTE MARIE ROSENKILDE, Thue Walter Schwartz · 2004 · Apmis
52. Engineering Nanocomposite Materials for Cancer Therapy
    Caterina Minelli, Stuart B. Lowe, Molly M. Stevens · 2010 · Small
53. Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales
    Asmaa El-Kenawi, Azza B. El‐Remessy · 2013 · British Journal of Pharmacology
54. Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies
    Michael R. Horsman, Dietmar W. Siemann · 2006 · Cancer Research
55. Toward an Image-Guided Microbeam Radiation Therapy Using Gadolinium-Based Nanoparticles
    Géraldine Le Duc, Imen Miladi, Christophe Alric, Pierre Mowat, Elke Bräuer‐Krisch, Audrey Bouchet, Enam A. Khalil, Claire Billotey, Marc F Janier, François Lux et al. · 2011 · ACS Nano
56. The Inflammatory Tumor Microenvironment and Its Impact on Cancer Development
    Karin E. de Visser, Lisa M. Coussens · 2006 · KARGER eBooks
57. Oral squamous cell carcinoma: Etiology, pathogenesis and prognostic value of genomic alterations
    Ravi Mehrotra, S Yadav · 2006 · Indian Journal of Cancer
58. Plaque Neovascularization and Antiangiogenic Therapy for Atherosclerosis
    Brendan J. Doyle, Noel M. Caplice · 2007 · Journal of the American College of Cardiology
59. Antiangiogenic therapies for high-grade glioma
    Andrew David Norden, Jan Drappatz, Patrick Yung Wen · 2009 · Nature Reviews Neurology
60. Monitoring Response to Anticancer Therapy by Targeting Microbubbles to Tumor Vasculature
    Grzegorz J. Korpanty, Juliet G. Carbon, Paul Arthur Grayburn, Jason B. Fleming, Rolf A. Brekken · 2007 · Clinical Cancer Research
61. Pancreatic Endocrine Tumors: Tumor Blood Flow Assessed with Perfusion CT Reflects Angiogenesis and Correlates with Prognostic Factors1
    Gaspard d’Assignies, Anne Couvelard, Stéphane Bahrami, Marie‐Pierre Vullierme, Pascal R. Hammel, Olivia Hentic, Alain Sauvanet, Pierre Bédossa, Philippe B Ruszniewski, Valérie Vilgrain · 2008 · Radiology
62. Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
    Alice Santi, Fernanda Grande Kugeratski, Sara R. Zanivan · 2017 · PROTEOMICS
63. Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy
    Yang, Shu, Gao, Huile · 2017 · Pharmacological Research
64. Formation and role of exosomes in cancer
    Lindsey T. Brinton, Hillary S. Sloane, MARK A. KESTER, Kimberly A. Kelly · 2014 · Cellular and Molecular Life Sciences
65. Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake
    Kosuke Kaji, Norihisa Nishimura, Kenichiro Seki, Shinya Sato, Soichiro Saikawa, Keisuke Nakanishi, Masanori Furukawa, Hideto Kawaratani, Mitsuteru Kitade, Kei Moriya et al. · 2017 · International Journal of Cancer
66. Integrin Targeted Delivery of Chemotherapeutics
    Kai Chen, Xiaoyuan Shawn Chen · 2011 · Theranostics
67. Mechanisms of new blood-vessel formation and proliferative heterogeneity of endothelial cells
    Hisamichi Naito, Tomohiro Iba, Nobuyuki Takakura · 2020 · International Immunology
68. Sunitinib Acts Primarily on Tumor Endothelium rather than Tumor Cells to Inhibit the Growth of Renal Cell Carcinoma
    Dan Huang, Yan Ding, Yan Li, Wang-Mei Luo, Zhong-Fa Zhang, John Snider, Kristin J. VandenBeldt, Chao-Nan Qian, Bin Tean Teh · 2010 · Cancer Research
69. Pleiotropic roles of matrix metalloproteinases in tumor angiogenesis: Contrasting, overlapping and compensatory functions
    Elena I. Deryugina, James P. Quigley · 2009 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
70. Antiangiogenic effects of flavonoids and chalcones
    Ján Mojžíš, Lenka Varinská, Gabriela Mojžišová, Irena P. Kostova, Ladislav Mirossay · 2008 · Pharmacological Research
71. Sinusoidal remodeling and angiogenesis: A new function for the liver-specific pericyte?
    June Sung Lee, David Semela, John Peter Iredale, Vijay H. Shah · 2007 · Hepatology
72. Crosstalk Between Long Non-coding RNAs, Micro-RNAs and mRNAs: Deciphering Molecular Mechanisms of Master Regulators in Cancer
    Eduardo López–Urrutia, Lilia Patricia Bustamante-Montes, Diego Ladrón de Guevara Cervantes, Carlos Pérez‐Plasencia, Alma Delia Campos-Parra · 2019 · Frontiers in Oncology
73. Inorganic Biomaterials for Regenerative Medicine
    Anna M. Brokesh, Akhilesh K. Gaharwar · 2020 · ACS Applied Materials & Interfaces
74. Recent Trends in Multifunctional Liposomal Nanocarriers for Enhanced Tumor Targeting
    Federico Perche, Vladimir P. Torchilin · 2013 · Journal of Drug Delivery
75. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment
    Lucie Kopfstein, Gerhard Christofori · 2006 · Cellular and Molecular Life Sciences
76. Sp1 Is Involved in Akt-mediated Induction of VEGF Expression through an HIF-1–independent Mechanism
    Nabendu Pore, Shuang Liu, Hui‐Kuo G. Shu, Bin Li, Daphne Adele Haas-Kogan, David Stokoe, Julie Milanini, Gilles Pagès, Donald M. O’Rourke, Eric J. Bernhard et al. · 2004 · Molecular Biology of the Cell
77. Angiogenetic Signaling through Hypoxia
    Claudia Schlueter, Holger Weber, Britta Meyer, Piere Rogalla, Kerstin Röser, Sven Hauke, Jörn Bullerdiek · 2005 · American Journal Of Pathology
78. Tumor Hypoxia: Impact on Radiation Therapy and Molecular Pathways
    Brita Singers Sørensen, Michael R. Horsman · 2020 · Frontiers in Oncology
79. Preparation of peptide-conjugated quantum dots for tumor vasculature-targeted imaging
    Weibo Cai, Xiaoyuan Shawn Chen · 2008 · Nature Protocols
80. Molecular Anatomy of Breast Cancer Stroma and Its Prognostic Value in Estrogen Receptor–Positive and –Negative Cancers
    Giampaolo Bianchini, Yuan Qi, Ricardo H. Álvarez, Takayuki Iwamoto, Charles Coutant, Nuhad K. Ibrahim, Vicente Valero, Massimo Cristofanilli, Marjorie C. Green, Laszlo George Radvanyi et al. · 2010 · Journal of Clinical Oncology
81. Neutrophils: important contributors to tumor progression and metastasis
    Swierczak, Agnieszka, Mouchemore, Kellie A., Hamilton, John A., Anderson, Robin L. · 2015 · Cancer and Metastasis Reviews
82. Systemic Induction of the Angiogenesis Switch by the Tetraspanin D6.1A/CO-029
    Sabine Gesierich, Igor Berezovskiy, Eduard Ryschich, Margot Zöller · 2006 · Cancer Research
83. Sunitinib
    Georgios S. Papaetis, Kostas Syrigos · 2009 · BioDrugs
84. Emerging roles of exosomes during epithelial–mesenchymal transition and cancer progression
    David W. Greening, Shashi K. Gopal, Rommel A. Mathias, Lin Liu, Jingyi Sheng, Hong‐Jian Zhu, Richard J. Simpson · 2015 · Seminars in Cell and Developmental Biology
85. Regulator of G-protein signaling-5 induction in pericytes coincides with active vessel remodeling during neovascularization
    Mario Berger, Gabriele Bergers, Bernd Arnold, Günter Joachim Hämmerling, Ruth Ganß · 2005 · Blood
86. Cancer-Targeted Optical Imaging with Fluorescent Zinc Oxide Nanowires
    Hao Hong, Jian Zhong Shi, Yunan Yang, Yin Zhang, Jonathan W. Engle, Robert J. Nickles, Xudong Wang, Weibo Cai · 2011 · Nano Letters
87. Nuclear Interleukin-33 Is Generally Expressed in Resting Endothelium but Rapidly Lost upon Angiogenic or Proinflammatory Activation
    Axel M. Küchler, Jürgen Pollheimer, Johanna Balogh, Jon Sponheim, Linda Manley, Dag Reidar Sørensen, Paula M. De Angelis, Helge Scott, Guttorm Haraldsen · 2008 · American Journal Of Pathology
88. Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities
    Chia‐Jui Weng, Gow‐Chin Yen · 2012 · Cancer and Metastasis Reviews
89. Melatonin and Cancer Hallmarks
    Wamidh H. Talib · 2018 · Molecules
90. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green
    Claire Egloff‐Juras, Lina Bezdetnaya, Gilles Dolivet, Henri‐Pierre Lassalle · 2019 · International Journal of Nanomedicine
91. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis
    John R. Basile, ROGERIO MORAES CASTILHO, Vanessa P. Williams, Jorge Silvio Gutkind · 2006 · Proceedings of the National Academy of Sciences
92. Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
    Muthu Kumaraswamy Shanmugam, Sudha R. Warrier, Alan Prem Kumar, Gautam Sethi, Frank Arfuso · 2017 · Current Vascular Pharmacology
93. Angiogenic inhibitors: a new therapeutic strategy in oncology
    Giampietro Gasparini, Raffaele Longo, Masakazu Toi, Napoleone Ferrara · 2005 · Nature Clinical Practice Oncology
94. Trends and Challenges in Tumor Anti-Angiogenic Therapies
    József Jászai, Mirko H. H. Schmidt · 2019 · Cells
95. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides
    Patrick Ying Kit Yue, Nai Ki Mak, Yuen‐Kit Cheng, Kar Wah Leung, Tzi Bun Ng, David Tai Ping Fan, Hin Wing Yeung, Ricky Ngok‐Shun Wong · 2007 · Chinese Medicine
96. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
    Wamidh H. Talib, Ahmad Riyad Alsayed, Alaa Abuawad, Safa Daoud, Asma Ismail Mahmod · 2021 · Molecules
97. Monocytes and Macrophages in Cancer: Development and Functions
    David M. Richards, Jan Hettinger, Markus Feuerer · 2012 · Cancer Microenvironment
98. The Role of IL-1β in the Early Tumor Cell–Induced Angiogenic Response
    Yaron Carmi, Shahar Dotan, Peleg Rider, Irena Kaplanov, Malka R. White, Rona Baron, Shai Abutbul, Monica Huszar, Charles Anthony Dinarello, Ron N. Apte et al. · 2013 · The Journal of Immunology
99. Genetically Engineered Mouse Models in Cancer Research
    Jessica C. Walrath, Jessica J. Hawes, Terry Van Dyke, Karlyne M. Reilly · 2010 · Advances in cancer research
100. Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
     A. Farina, A. Mackay · 2014 · Cancers